TEVA PHARMACEUTICAL INDUSTRIES LTD Annual Depreciation in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Teva Pharmaceutical Industries Ltd annual Depreciation history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd annual Depreciation for 2023 was $537M, a 6.77% decline from 2022.
  • Teva Pharmaceutical Industries Ltd annual Depreciation for 2022 was $576M, a 9.09% increase from 2021.
  • Teva Pharmaceutical Industries Ltd annual Depreciation for 2021 was $528M, a 1.68% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $537M -$39M -6.77% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 $576M +$48M +9.09% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $528M -$9M -1.68% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 $537M -$72M -11.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $609M -$67M -9.91% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $676M +$44M +6.96% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 $632M +$131M +26.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $501M +$52M +11.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $449M -$15M -3.23% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $464M +$6M +1.31% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 $458M +$30M +7.01% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 $428M +$70M +19.6% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $358M -$90M -20.1% Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
2010 $448M Jan 1, 2010 Dec 31, 2010 20-F 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.